Huadong Medicine Co.,Ltd

Chinese companies are conducting multiple clinical trials for obesity medicines, especially domestically, and ramping up the production of semaglutide generics, meaning there’s no lack of drug options

Chinese companies are conducting multiple clinical trials for obesity medicines, especially domestically, and ramping up the production of semaglutide generics, meaning there’s no lack of drug options

Chinese biotech funding backed by venture capital and private equity firms experienced a much-needed uplift over the past few weeks, thanks partly to investor interest in assets with novel modalities

In 2023, China was the second largest product/technology exporter in the global biopharmaceutical pipeline, with 143 pipeline transactions, runner up only to the US. In China’s biopharmaceutical indus